Viemed Healthcare (VMD) Gains from Investment Securities (2018 - 2026)

Viemed Healthcare has reported Gains from Investment Securities for 9 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities rose 10988.89% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 1109.12% YoY), and the FY2025 full-year result was $1.7 million, up 413.02% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $2.0 million, up from $2000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $3.1 million in Q2 2023, with the low at -$2.6 million in Q2 2022.
• Historically, Gains from Investment Securities has averaged $312000.0 across 5 years, with a median of $101000.0 in 2025.
• The largest YoY upside for Gains from Investment Securities was 30525.0% in 2022 against a maximum downside of 827.9% in 2022.
• Viemed Healthcare's Gains from Investment Securities stood at $148000.0 in 2022, then tumbled by 556.76% to -$676000.0 in 2023, then slipped by 7.54% to -$727000.0 in 2024, then surged by 100.28% to $2000.0 in 2025, then surged by 99700.0% to $2.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $2.0 million (Q1 2026), $2000.0 (Q4 2025), and $101000.0 (Q3 2025), per Business Quant data.